<DOC>
	<DOCNO>NCT01725906</DOCNO>
	<brief_summary>We aim compare efficacy genotypic resistance guide sequential therapy vs. empiric therapy third line therapy . Factors affect eradication rate , include antibiotic resistance , CYP2C19 polymorphism , CagA VacA status also assess .</brief_summary>
	<brief_title>Genotypic Resistance Guided Therapy Helicobacter Pylori Eradication</brief_title>
	<detailed_description>The primary aim study compare regimens select use either one method ( 1 ) genotypic resistance guide versus ( 2 ) medication history guide therapy . ( rather compare efficacy drug ) .</detailed_description>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Patients age great 20 year persistent H. pylorus infection least two treatment willing receive third line rescue regimen consider eligible enrollment . Patients exclude study one follow criterion present : ( 1 ) child teenager age less 20 year , ( 2 ) history gastrectomy , ( 3 ) gastric malignancy , include adenocarcinoma lymphoma , ( 4 ) previous allergic reaction antibiotic ( Amoxicillin , Klaricid , Cravit ) prompt pump inhibitor ( esomeprazole ) , ( 5 ) contraindication treatment drug , ( 6 ) pregnant lactate woman , ( 7 ) severe concurrent disease .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>genotypic resistance guide therapy</keyword>
</DOC>